1. WHO. World malaria report 2019. Geneva: World Health Organization; 2019. https://www.who.int/publications-detail-redirect/9789241565721.
2. Baird JK. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009;22 3:508-34; doi: 10.1128/CMR.00008-09. https://www.ncbi.nlm.nih.gov/pubmed/19597012.
3. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195 7:927-33; doi: 10.1086/512241. https://www.ncbi.nlm.nih.gov/pubmed/17330781.
4. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14 10:982-91; doi: 10.1016/S1473-3099(14)70855-2. https://www.ncbi.nlm.nih.gov/pubmed/25213732.
5. Singh S, Chitnis CE. Molecular Signaling Involved in Entry and Exit of Malaria Parasites from Host Erythrocytes. Cold Spring Harb Perspect Med. 2017;7 10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28507195&query_hl=1.
6. Singh S, Alam MM, Pal-Bhowmick I, Brzostowski JA, Chitnis CE. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 2010;6 2:e1000746. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20140184&query_hl=1.
7. Mueller I, Shakri AR, Chitnis CE. Development of vaccines for Plasmodium vivax malaria. Vaccine. 2015;33 52:7489-95; doi: 10.1016/j.vaccine.2015.09.060. https://www.ncbi.nlm.nih.gov/pubmed/26428453.
8. Tham WH, Beeson JG, Rayner JC. Plasmodium vivax vaccine research - we've only just begun. Int J Parasitol. 2017;47 2-3:111-8; doi: 10.1016/j.ijpara.2016.09.006. https://www.ncbi.nlm.nih.gov/pubmed/27899329.
9. Noulin F, Borlon C, Van Den Abbeele J, D'Alessandro U, Erhart A. 1912-2012: a century of research on Plasmodium vivax in vitro culture. Trends Parasitol. 2013;29 6:286-94; doi: 10.1016/j.pt.2013.03.012. https://www.ncbi.nlm.nih.gov/pubmed/23623759.
10. Udomsangpetch R, Kaneko O, Chotivanich K, Sattabongkot J. Cultivation of Plasmodium vivax. Trends Parasitol. 2008;24 2:85-8; doi: 10.1016/j.pt.2007.09.010. https://www.ncbi.nlm.nih.gov/pubmed/18180202.
11. Howes RE, Reiner RC, Jr., Battle KE, Longbottom J, Mappin B, Ordanovich D, et al. Plasmodium vivax Transmission in Africa. PLoS Negl Trop Dis. 2015;9 11:e0004222; doi: 10.1371/journal.pntd.0004222. https://www.ncbi.nlm.nih.gov/pubmed/26587988.
12. Mercereau-Puijalon O, Menard D. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol. 2010;17 3:176-83; doi: 10.1016/j.tracli.2010.06.005. https://www.ncbi.nlm.nih.gov/pubmed/20655790.
13. Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes. Blood. 2015;125 8:1314-24; doi: 10.1182/blood-2014-08-596015. https://www.ncbi.nlm.nih.gov/pubmed/25414440.
14. Gruszczyk J, Huang RK, Chan LJ, Menant S, Hong C, Murphy JM, et al. Cryo-EM structure of an essential Plasmodium vivax invasion complex. Nature. 2018;559 7712:135-9; doi: 10.1038/s41586-018-0249-1. https://www.ncbi.nlm.nih.gov/pubmed/29950717.
15. Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science. 2018;359 6371:48-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29302006&query_hl=1.
16. Galinski MR, Medina CC, Ingravallo P, Barnwell JW. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell. 1992;69 7:1213-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1617731&query_hl=1.
17. Gruszczyk J, Lim NT, Arnott A, He WQ, Nguitragool W, Roobsoong W, et al. Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement. Proc Natl Acad Sci U S A. 2016;113 2:E191-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26715754&query_hl=1.
18. He WQ, Karl S, White MT, Nguitragool W, Monteiro W, Kuehn A, et al. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand. PLoS Negl Trop Dis. 2019;13 8:e0007596. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31425514&query_hl=1.
19. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295 6:302-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=778616&query_hl=1.
20. Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature. 2011;480 7378:534-7; doi: 10.1038/nature10606. https://www.ncbi.nlm.nih.gov/pubmed/22080952.
21. Franca CT, He WQ, Gruszczyk J, Lim NT, Lin E, Kiniboro B, et al. Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children. PLoS Negl Trop Dis. 2016;10 9:e0005014. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=27677183&query_hl=1.
22. Hietanen J, Chim-Ong A, Chiramanewong T, Gruszczyk J, Roobsoong W, Tham WH, et al. Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding Proteins. Infect Immun. 2015;84 3:677-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26712206&query_hl=1.
23. Diez Benavente E, Campos M, Phelan J, Nolder D, Dombrowski JG, Marinho CRF, et al. A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malaria. PLoS Genet. 2020;16 2:e1008576; doi: 10.1371/journal.pgen.1008576. https://www.ncbi.nlm.nih.gov/pubmed/32053607.
24. Brashear AM, Fan Q, Hu Y, Li Y, Zhao Y, Wang Z, et al. Population genomics identifies a distinct Plasmodium vivax population on the China-Myanmar border of Southeast Asia. PLoS Negl Trop Dis. 2020;14 8:e0008506; doi: 10.1371/journal.pntd.0008506. https://www.ncbi.nlm.nih.gov/pubmed/32745103.
25. Ford A, Kepple D, Abagero BR, Connors J, Pearson R, Auburn S, et al. Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes. PLoS Negl Trop Dis. 2020;14 10:e0008234; doi: 10.1371/journal.pntd.0008234. https://www.ncbi.nlm.nih.gov/pubmed/33044985.
26. Auburn S, Getachew S, Pearson RD, Amato R, Miotto O, Trimarsanto H, et al. Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite Mechanisms. J Infect Dis. 2019;220 11:1738-49; doi: 10.1093/infdis/jiz016. https://www.ncbi.nlm.nih.gov/pubmed/30668735.
27. de Oliveira TC, Rodrigues PT, Menezes MJ, Goncalves-Lopes RM, Bastos MS, Lima NF, et al. Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax. PLoS Negl Trop Dis. 2017;11 7:e0005824; doi: 10.1371/journal.pntd.0005824. https://www.ncbi.nlm.nih.gov/pubmed/28759591.
28. Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nat Genet. 2016;48 8:953-8; doi: 10.1038/ng.3588. https://www.ncbi.nlm.nih.gov/pubmed/27348298.
29. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25 11:1451-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19346325&query_hl=1.
30. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123 3:585-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2513255&query_hl=1.
31. Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133 3:693-709. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8454210&query_hl=1.
32. McDonald JH, Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature. 1991;351 6328:652-4; doi: 10.1038/351652a0. https://www.ncbi.nlm.nih.gov/pubmed/1904993.
33. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33 7:1870-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=27004904&query_hl=1.
34. Poon AF, Frost SD, Pond SL. Detecting signatures of selection from DNA sequences using Datamonkey. Methods Mol Biol. 2009;537:163-83; doi: 10.1007/978-1-59745-251-9_8. https://www.ncbi.nlm.nih.gov/pubmed/19378144.
35. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22 5:1208-22; doi: 10.1093/molbev/msi105. https://www.ncbi.nlm.nih.gov/pubmed/15703242.
36. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, et al. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol. 2013;30 5:1196-205; doi: 10.1093/molbev/mst030. https://www.ncbi.nlm.nih.gov/pubmed/23420840.
37. Cockerham CC. Analyses of gene frequencies. Genetics. 1973;74 4:679-700. https://www.ncbi.nlm.nih.gov/pubmed/17248636.
38. Cockerham CC, Weir BS. Covariances of relatives stemming from a population undergoing mixed self and random mating. Biometrics. 1984;40 1:157-64. https://www.ncbi.nlm.nih.gov/pubmed/6733226.
39. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155 2:945-59. https://www.ncbi.nlm.nih.gov/pubmed/10835412.
40. Hubisz MJ, Falush D, Stephens M, Pritchard JK. Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour. 2009;9 5:1322-32; doi: 10.1111/j.1755-0998.2009.02591.x. https://www.ncbi.nlm.nih.gov/pubmed/21564903.
41. Earl DA, Vonholdt BM. STRUCTURE HARVESTER: a website and program for visualizing STRUCTURE output and implementing the Evanno method. Conserv Genet Resour. 2012;4 2:359-61; doi: 10.1007/s12686-011-9548-7. <Go to ISI>://WOS:000303536400036.
42. Evanno G, Regnaut S, Goudet J. Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol Ecol. 2005;14 8:2611-20; doi: 10.1111/j.1365-294X.2005.02553.x. <Go to ISI>://WOS:000229961500029.
43. Jakobsson M, Rosenberg NA. CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure. Bioinformatics. 2007;23 14:1801-6; doi: 10.1093/bioinformatics/btm233. <Go to ISI>://WOS:000249248300012.
44. Rosenberg NA. DISTRUCT: a program for the graphical display of population structure. Mol Ecol Notes. 2004;4 1:137-8; doi: 10.1046/j.1471-8286.2003.00566.x. <Go to ISI>://WOS:000189159500042.
45. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49 W1:W293-W6; doi: 10.1093/nar/gkab301. https://www.ncbi.nlm.nih.gov/pubmed/33885785.
46. Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16 1:37-48. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10331250&query_hl=1.
47. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit. 2008;21 4:243-55; doi: 10.1002/jmr.893. https://www.ncbi.nlm.nih.gov/pubmed/18496882.
48. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4; doi: 10.1186/1471-2105-8-4. https://www.ncbi.nlm.nih.gov/pubmed/17207271.
49. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10 6:845-58; doi: 10.1038/nprot.2015.053. https://www.ncbi.nlm.nih.gov/pubmed/25950237.
50. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001;98 18:10037-41; doi: 10.1073/pnas.181342398. https://www.ncbi.nlm.nih.gov/pubmed/11517324.
51. Bittencourt NC, Silva A, Virgili NS, Schappo AP, Gervasio J, Pimenta TS, et al. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response. PLoS Negl Trop Dis. 2020;14 7:e0008471; doi: 10.1371/journal.pntd.0008471. https://www.ncbi.nlm.nih.gov/pubmed/32639964.
52. Ruan W, Zhang LL, Feng Y, Zhang X, Chen HL, Lu QY, et al. Genetic diversity of Plasmodium Vivax revealed by the merozoite surface protein-1 icb5-6 fragment. Infect Dis Poverty. 2017;6 1:92; doi: 10.1186/s40249-017-0302-6. https://www.ncbi.nlm.nih.gov/pubmed/28578709.
53. Arnott A, Mueller I, Ramsland PA, Siba PM, Reeder JC, Barry AE. Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). PLoS Negl Trop Dis. 2013;7 10:e2506; doi: 10.1371/journal.pntd.0002506. https://www.ncbi.nlm.nih.gov/pubmed/24205419.
54. Rougeron V, Elguero E, Arnathau C, Acuna Hidalgo B, Durand P, Houze S, et al. Human Plasmodium vivax diversity, population structure and evolutionary origin. PLoS Negl Trop Dis. 2020;14 3:e0008072; doi: 10.1371/journal.pntd.0008072. https://www.ncbi.nlm.nih.gov/pubmed/32150544.
55. Nkhoma SC, Nair S, Al-Saai S, Ashley E, McGready R, Phyo AP, et al. Population genetic correlates of declining transmission in a human pathogen. Mol Ecol. 2013;22 2:273-85; doi: 10.1111/mec.12099. https://www.ncbi.nlm.nih.gov/pubmed/23121253.
56. Li Y, Hu Y, Zhao Y, Wang Q, Ngassa Mbenda HG, Kittichai V, et al. Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination. Malar J. 2020;19 1:145; doi: 10.1186/s12936-020-03221-9. http://www.ncbi.nlm.nih.gov/pubmed/32268906.
57. Liu Z, Soe TN, Zhao Y, Than A, Cho C, Aung PL, et al. Geographical heterogeneity in prevalence of subclinical malaria infections at sentinel endemic sites of Myanmar. Parasit Vectors. 2019;12 1:83; doi: 10.1186/s13071-019-3330-1. https://www.ncbi.nlm.nih.gov/pubmed/30777127.
58. Zhao Y, Zeng J, Zhao Y, Liu Q, He Y, Zhang J, et al. Risk factors for asymptomatic malaria infections from seasonal cross-sectional surveys along the China-Myanmar border. Malar J. 2018;17 1:247; doi: 10.1186/s12936-018-2398-y. https://www.ncbi.nlm.nih.gov/pubmed/29973194.
59. Weedall GD, Conway DJ. Detecting signatures of balancing selection to identify targets of anti-parasite immunity. Trends Parasitol. 2010;26 7:363-9; doi: 10.1016/j.pt.2010.04.002. https://www.ncbi.nlm.nih.gov/pubmed/20466591.
60. Demogines A, Abraham J, Choe H, Farzan M, Sawyer SL. Dual host-virus arms races shape an essential housekeeping protein. PLoS Biol. 2013;11 5:e1001571; doi: 10.1371/journal.pbio.1001571. https://www.ncbi.nlm.nih.gov/pubmed/23723737.
61. Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol. 2010;17 4:438-44; doi: 10.1038/nsmb.1772. https://www.ncbi.nlm.nih.gov/pubmed/20208545.
62. Laurens MB. The Promise of a Malaria Vaccine-Are We Closer? Annu Rev Microbiol. 2018;72:273-92; doi: 10.1146/annurev-micro-090817-062427. https://www.ncbi.nlm.nih.gov/pubmed/30200856.
63. Ntege EH, Takashima E, Morita M, Nagaoka H, Ishino T, Tsuboi T. Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates. Expert Rev Vaccines. 2017;16 8:769-79; doi: 10.1080/14760584.2017.1341317. https://www.ncbi.nlm.nih.gov/pubmed/28604122.
64. Remarque EJ, Faber BW, Kocken CH, Thomas AW. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun. 2008;76 6:2660-70; doi: 10.1128/IAI.00170-08. https://www.ncbi.nlm.nih.gov/pubmed/18378635.
65. Osier FH, Weedall GD, Verra F, Murungi L, Tetteh KK, Bull P, et al. Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. Infect Immun. 2010;78 11:4625-33; doi: 10.1128/IAI.00576-10. https://www.ncbi.nlm.nih.gov/pubmed/20732997.
66. Koepfli C, Rodrigues PT, Antao T, Orjuela-Sanchez P, Van den Eede P, Gamboa D, et al. Plasmodium vivax Diversity and Population Structure across Four Continents. PLoS Negl Trop Dis. 2015;9 6:e0003872; doi: 10.1371/journal.pntd.0003872. https://www.ncbi.nlm.nih.gov/pubmed/26125189.
67. Pearson RD, Amato R, Auburn S, Miotto O, Almagro-Garcia J, Amaratunga C, et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat Genet. 2016;48 8:959-64; doi: 10.1038/ng.3599. https://www.ncbi.nlm.nih.gov/pubmed/27348299.
68. Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, Senn N, et al. Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med. 2012;9 9:e1001305; doi: 10.1371/journal.pmed.1001305. https://www.ncbi.nlm.nih.gov/pubmed/22973182.
69. Muller I, Bockarie M, Alpers M, Smith T. The epidemiology of malaria in Papua New Guinea. Trends Parasitol. 2003;19 6:253-9; doi: 10.1016/s1471-4922(03)00091-6. https://www.ncbi.nlm.nih.gov/pubmed/12798082.